Loading viewer...
investor_presentation
Format: PDF investor_presentation
M&G investor presentation dated March 2022.
2021 Full Year Results
This pre sentation ismade byM&G plc(‘M&G’) .Forthepurpose s ofthisnotice, ‘pre sentation’ shall me an and include thedocume nt that follows and anyoral pre sentation, anyque stion -and-answer se ssion and any
other written ororal material delivered ordistributed byM&G inconnection with it.
This pre sentation may contain certain ‘forward -looking statements’ with re spect toM&G and itsaffiliate s (the ‘M&G Group’), itsplans, itscurrent goals and expectations re lating tofuture financial condition,
performance, results, operating environment, strategy and obje ctive s .Statements thatarenothistorical facts, including statements about M&G’s be liefs and expe ctations andincluding, without limitation, statements
containing thewords ‘may’, ‘will’, ‘should’, ‘continue’, ‘aims’, ‘e stimate s’, ‘proje cts’, ‘be lieve s’, ‘intends’, ‘expects’, ‘plans’, ‘seeks’, ‘outlook’ and ‘anticipate s’, and words ofsimilar meaning, are forward -looking
statements .The se statements arebased onplans, e stimate s and proje ctions asatthetime they aremade, and therefore persons re ading thisannouncement arecautioned against placing undue re liance onforward -
looking statements .
Bytheir nature, forward -looking statements involve inhe rent assumptions, riskand uncertainty, asthey generally re late tofuture events and circumstances that may bebe yond theM&G Group’s control .Anumber of
important factors could cause M&G’s actual future financial condition orperformance orothe r indicated re sults todiffer mate rially from those indicated inanyforward -looking statement .Such factors include, butare
notlimited to,UKdomestic and global economic and business conditions (including thepolitical, legal and e conomic effects oftheUK’s decision toleave theEurope an Union) ;market -re lated conditions and risk,
including fluctuations inintere st rates and exchange rates, thepotential forasustained low-interest rate environment, corporate liquidity riskand thefuture trading value oftheshare s ofM&G ;inve stment portfolio -
re lated risks, such astheperformance offinancial markets generally ;thepolicie s and actions ofregulatory authoritie s, including, forexample, new governme nt initiatives ;theimpact ofcompetition, e conomic
uncertainty, inflation and deflation ;theeffect onM&G’s busine ss and re sults from, inparticular, mortality and morbidity trends, longevity assumptions, lapse rate s and policy renewal rate s ;thetiming, impact and
other uncertaintie s offuture acquisitions orcombinations within re levant industrie s ;theimpact ofinternal projects andother strategic actions, such astransformation programmes, failing tomeet their objective s ;the
impact ofope rational risks, including riskassociated with third party arrangements, reliance onthird party distribution channe ls and disruption totheavailability, confidentiality orintegrity ofM&G’s ITsystems (or
Preview truncated — download the full document for the complete content.
earnings
52 Pages
investor_presentation
51 Pages
Iovance Biotherapeutics, Inc